Search results

Skip to results

Refine results

Showing all

Showing 1 to 20 results of 238

What we doOur work
What we doOur work

Something New: Covid Living

Created by poet Koleka Putuma and illustrator Ivvy Chen, this animation beautifully captures young people’s approach to dealing with the challenges of Covid-19 lockdowns.
NewsQ&A
NewsQ&A

Why do we need a new generation of Covid-19 vaccines?

The first Covid-19 vaccines have been very effective, but there’s plenty of room for improvement, especially for dealing with new variants. Charlie Weller talks about the…
Author
Who we are
Who we are

Modern slavery statement

Wellcome is strongly opposed to slavery and human trafficking. We strive to act ethically and with integrity in all our business dealings and relationships to ensure that…
What we do
What we do

Brexit

We worked with EU institutions, the UK government, the research sector and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.
Who we arePeople

Rachel Huxley

Head of Mitigation

Rachel joined Wellcome in August 2023 to lead the research programme to support science and evidence generation of the health co-benefits of mitigation in order to drive low-…
News
News

Learning from pandemics

Charlie Weller has been at Wellcome since 2014 and Head of Prevention since September 2021. Her work at Wellcome has included leading the funding response to the West African…
Grant fundingGuidance
Grant fundingGuidance

Funding advisory committees

We have a number of committees, panels and expert review groups that shortlist and interview people who have applied for funding. 
Who we arePeople

Beth Thompson

Chief Strategy Officer

Beth is Chief Strategy Officer, responsible for the work of the strategy and programme office, government relations and strategic partnerships, policy, and transition and…
Who we arePeople

Philomena Gibbons

Associate Director, Transition and Legacy

Philomena Gibbons leads work across Wellcome to manage the completion and transition of work not continuing under Wellcome’s new strategy.